Innovations in Electrophysiology

Graphene Core 3

Graphene Core 3

Advanced tools for biomedical implants and neural interface applications.
Graphene Core 3
2020 to 2023
H2020-SGA-FET-GRAPHENE-2019 (Graphene FET Flagship core project)

As the demand for healthcare services continues to increase, so does the demand for novel healthcare solutions. These solutions should be more effective, cost less, prevent and cure disease, and should be equally effective throughout the world. Graphene is paving the way for novel diagnosis and treatments, thanks to its unique properties, such as high surface area, electron mobility, and functionalization potential; all favorable for biomedical technologies.

MCS is involved in the Biomedical Technologies work package of the Graphene Core 3 project. The main objective is to develop up-scalable and standardized technology processes for the fabrication of flexible neural probes for in vivo applications and rigid neural devices for in vitro applications. With the help of MCS, this project will develop, test, and validate deep brain implants as well as retina implants. The in vivo neural probes will combine functionalities such as electrical recording, electrical stimulation, release of therapeutic agents and biochemical sensing. The electronic equipment, partly developed at MCS, will be capable to operate wired as well as wirelessly. Finally, the neural devices will be adapted to standard commercial biomedical and neuroscience electronic equipment.


Graphene Applications - Biomedical Technologies


Main project partners: 
Catalan Institute of Nanoscience and Nanotechnology (ICN2), Barcelona; The Spanish National Research Council (CSIC), Madrid; Italian Institute of Technology (IIT), Genova; Guger Technologies OG (g.tec), Graz; The University of Manchester; Sorbonne University Paris; University College London (UCL); August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona;